1-2-dielaidoylphosphatidylethanolamine and Central-Nervous-System-Diseases

1-2-dielaidoylphosphatidylethanolamine has been researched along with Central-Nervous-System-Diseases* in 1 studies

Other Studies

1 other study(ies) available for 1-2-dielaidoylphosphatidylethanolamine and Central-Nervous-System-Diseases

ArticleYear
Cationic liposome-mediated DNA transfection in organotypic explant cultures of the ventral mesencephalon.
    Gene therapy, 1999, Volume: 6, Issue:2

    We have examined the potential of cationic liposomes as a tool for approaches to gene therapy in the CNS. Our previous work has shown that cationic liposomes formulated from 3 beta-[N-(N',N'-dimethylaminoethane)carbamoyl] cholesterol (DC-Chol) and dioleoyl-L-alpha-phosphatidylethanolamine (DOPE) could achieve high transfection levels in a neuronal cell line (McQuillin et al. Neuroreport 1997; 8: 1481-1484). We therefore wished to assess transfection efficiencies in organotypic cultures from the brain with a reporter plasmid expressing E. coli beta-galactosidase in order to mimic an in vivo model. Explant cultures were generated according to the method of Stoppini et al (J Neurosci Meth 1991; 37: 173-182) with slight modifications. Brain slices were maintained on transparent porous membranes and were observed to maintain their intrinsic connectivity and cytoarchitecture to a large degree over periods of up to 6 weeks in culture. CNS tissue was obtained from rats at birth or 5 days after birth. After transfection beta-galactosidase expression was detected in cells of both neuronal and non-neuronal morphology. Control cultures were exposed to liposome alone and a plasmid that had the beta-galactosidase gene insert removed. Only low levels of endogenous beta-galactosidase reactivity were seen in these control cultures. DC-Chol/DOPE-mediated transfection was confirmed using a RT-PCR protocol capable of differentiating between untranscribed plasmid DNA and RNA generated from the transfected vector. These results suggest that cationic liposomes, particularly DC-Chol/DOPE liposomes, will be useful as delivery agents for gene transfer to CNS cells in vitro and possibly in vivo.

    Topics: Animals; beta-Galactosidase; Central Nervous System Diseases; Cholesterol; Culture Techniques; Gene Expression; Genetic Therapy; Liposomes; Mesencephalon; Phosphatidylethanolamines; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Transfection

1999